您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报(医学版)

• 论文 • 上一篇    下一篇

瘤内缓释治疗对B16黑色素瘤小鼠影响的实验研究

卜洁琼1,于保法2   

  1. 1. 山东大学医学院免疫研究所, 山东 济南 250012;2. 济南保法肿瘤医院, 山东 济南 250012
  • 收稿日期:2007-01-10 修回日期:1900-01-01 出版日期:2007-10-24 发布日期:2007-10-24
  • 通讯作者: 于保法

Slow intra-tumor release of drugs on B16 melonoma in mice

BU Jie-qiong1,YU Bao-fa2   

  1. 1. Institute of Immunology, School of Medicine, Shandong University;2. Jinan Baofa Cancer Hospital, Jinan 250012, Shandong, China
  • Received:2007-01-10 Revised:1900-01-01 Online:2007-10-24 Published:2007-10-24
  • Contact: YU Bao-fa

摘要: 目的:探讨肿瘤内缓释治疗对B16黑色素瘤的影响及其机制。方法:将皮下接种B16肿瘤细胞后的成瘤小鼠随机分成4组进行治疗:①生理盐水(NS)对照组,瘤内注射NS;②阿糖胞苷(Ara-C)对照组,瘤内注射Ara-C;③单纯缓释治疗组,瘤内注射Ara-C+缓释液;④免疫缓释液治疗组,瘤内注射Ara-C+缓释液+二硝基苯 (DNP)。4d后重复治疗,观察各组小鼠肿瘤的生长情况。两次治疗后1周分离瘤体,HE及网状纤维、弹力纤维、胶原纤维染色,观察瘤体病理改变,用流式细胞术检测脾内CD4+T细胞、CD8+T细胞浸润情况。结果:缓释治疗能够控制肿瘤的生长;HE染色显示,两缓释治疗组瘤内出现大片坏死区域,纤维特殊染色显示,两缓释治疗组三种纤维含量均明显增加(P<0.01);流式细胞术检测表明,缓释治疗组的CD4+T细胞数量明显增多(P<0.05),但CD4+/CD8+T比值无明显变化。结论:瘤内缓释治疗通过直接破坏肿瘤细胞及增加肿瘤抗原性,从而发挥明显的抗肿瘤作用,为肿瘤治疗提供了新的思路。

关键词: 抗原修饰 , 肿瘤内化疗, 二硝基苯酚, 缓释治疗, 黑色素瘤

Abstract: Objective: To explore the effects and mechanism of slow intra-tumor release of drugs on B16 melonoma in mice. Methods: Bearing-tumor mice were randomly divided into four groups: the normal saline group, the Ara-C group, the Ara-C plus releasing drugs group and the the Ara-C plus releasing drugs and DNP group. Four days later, mice were treated again and the gross tumor volume was determined. Then 1 week later, the contents of three fibers were detected in the interstitial substances of the tumor and the infiltrations of T cells were determined in the splenic organs. Results: HE staining results showed that there was a large part of stenosis in the tumor, the fibers in the matrix of tumor were significantly increased and the CD4+T cells were also significantly increased in the two slow-release groups. Conclusion: Slow-release of drugs into the tumor is one of effective managements for directly inhibiting tumor growth and preventing micro-metastasis.

Key words: Melanoma, Slow-release drug therapy, Intratumoral chemotherapy, Dinitrophenyl, Modified antigen

中图分类号: 

  • R737.14
[1] 董尧,宋亚林,田涛,高建国. 确诊8年未经治疗却无明显进展的阴茎恶性黑色素瘤1例报道[J]. 山东大学学报(医学版), 2017, 55(3): 125-126.
[2] 袁冰,李冉冉,韩明勇. 恶性黑色素瘤调节肺组织微环境并促进肿瘤肺转移的实验研究[J]. 山东大学学报(医学版), 2016, 54(11): 13-18.
[3] 张敏, 穆晓楠, 马伟元, 党宁宁, 张楠. 山东省皮肤恶性黑色素瘤患者的临床特征与预后危险因素分析(附61例报告)[J]. 山东大学学报(医学版), 2015, 53(11): 80-84.
[4] 朱守荣1,张芮2,曹永倩1,冯璋1,王一兵1. 慢病毒载体靶向携带survivin-siRNA对恶性黑色素瘤A375细胞的影响[J]. 山东大学学报(医学版), 2013, 51(5): 54-57.
[5] . 鼻腔鼻窦恶性黑色素瘤的诊断与治疗(附37例报告)[J]. 山东大学学报(医学版), 2009, 47(8): 93-96.
[6] 郭春 吴南 洪海洁 武文亮 何婧 于保法 高尚先 胡宝芳. 无细胞短棒状杆菌制剂联合瘤内缓释化疗对鼠黑色素瘤的抑制效应[J]. 山东大学学报(医学版), 2009, 47(5): 67-70.
[7] 马 鸣,李秀真,王 超,郭洪敏,马 鑫,张 旭 . MAGE-3抗原肽致敏DC疫苗抗膀胱癌细胞的体外实验[J]. 山东大学学报(医学版), 2008, 46(5): 485-489.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!